Gamma-Interferon-Inducible Lysosomal Thiol Reductase (GILT)
In 1988, the laboratory of Dr. Jeffrey Ravetch characterized a gene which is upregulated upon exposure to the cytokine, interferon-γ (IFN-γ). The protein is produced in a precursor form of 35 kDa and processed into a mature form of 30 kDa. The protein was originally named inducible protein 30 (IP30) and the gene named IFI30. IP30 is constitutively expressed in many antigen-presenting cells (APCs) and induced in other cell types including fibroblasts, endothelial cells, and keratinocytes (Maric et al. 2001; Lackman and Cresswell 2006; Phipps-Yonas et al. 2013a; Nguyen et al. 2016).
Homology to protein folding patterns of a cellular thiol reductase, thioredoxin, suggested that IP30 may be capable of breaking disulfide bonds. Indeed, a thioredoxin-like motif, CXXC, is found in the IP30 protein sequence and is conserved across species with IP30 homologs. IP30 reduces disulfide bonds, and the cysteines in the CXXC...
- Bergman CM, Marta CB, Maric M, Pfeiffer SE, Cresswell P, Ruddle NH. A switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-gamma-inducible lysosomal thiol reductase-free mice. J Immunol (Baltimore, Md: 1950). 2012;188:6001–9. doi:10.4049/jimmunol.1101898.CrossRefPubMedPubMedCentralGoogle Scholar
- Bogunovic B, Srinivasan P, Ueda Y, Tomita Y, Maric M. Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire. PLoS One. 2010;5:e10599. doi:10.1371/journal.pone.0010599.CrossRefPubMedPubMedCentralGoogle Scholar
- Kubo Y, Izumida M, Yashima Y, Yoshii-Kamiyama H, Tanaka Y, Yasui K, et al. Gamma-interferon-inducible, lysosome/endosome-localized thiolreductase, GILT, has anti-retroviral activity and its expression is counteracted by HIV-1. Oncotarget. 2016. doi:10.18632/oncotarget.12104.CrossRefPubMedPubMedCentralGoogle Scholar
- Maric M, Barjaktarevic I, Bogunovic B, Stojakovic M, Maric C, Vukmanovic S. Cutting edge: developmental up-regulation of IFN-gamma-inducible lysosomal thiol reductase expression leads to reduced T cell sensitivity and less severe autoimmunity. J Immunol. 2009;182:746–50. doi:10.4049/jimmunol.182.2.746.CrossRefPubMedGoogle Scholar
- O’Donnell PW, Haque A, Klemsz MJ, Kaplan MH, Blum JS. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells is STAT1-dependent but CIITA-independent. J Immunol. 2004;173:731–5. doi:10.4049/jimmunol.173.2.731.CrossRefPubMedGoogle Scholar
- Sealy R, Chaka W, Surman S, Brown SA, Cresswell P, Hurwitz JL. Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities. Clin Vaccine Immunol. 2008;15:713–9. doi:10.1128/CVI.00412-07.CrossRefPubMedPubMedCentralGoogle Scholar
- Xiang YJ, Guo MM, Zhou CJ, Liu L, Han B, Kong LY, et al. Absence of gamma-interferon-inducible lysosomal thiol reductase (GILT) is associated with poor disease-free survival in breast cancer patients. PLoS One. 2014;9:e109449. doi:10.1371/journal.pone.0109449.CrossRefPubMedPubMedCentralGoogle Scholar